CCG 50014

CAS No. 883050-24-6

CCG 50014 ( CCG-50014; CCG 50014; CCG50014 )

Catalog No. M17641 CAS No. 883050-24-6

CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 32 Get Quote
5MG 49 Get Quote
10MG 88 Get Quote
25MG 188 Get Quote
50MG 340 Get Quote
100MG 506 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCG 50014
  • Note
    Research use only, not for human use.
  • Brief Description
    CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.
  • Description
    CCG-50014 is a potent small molecule inhibitor of regulator of G-protein signaling protein 4 (RGS4).
  • Synonyms
    CCG-50014; CCG 50014; CCG50014
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    RGS16; RGS19; RGS4; RGS8
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    883050-24-6
  • Formula Weight
    316.35
  • Molecular Formula
    C16H13FN2O2S
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CC1=CC=C(C=C1)N1SC(=O)N(CC2=CC=C(F)C=C2)C1=O
  • Chemical Name
    4-[(4-fluorophenyl)methyl]-2-(4-methylphenyl)-1,2,4-thiadiazolidine-3,5-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Blazer LL, et al. Biochemistry, 2011, 50(15), 3181-3192.
molnova catalog
related products
  • 6-(4-Methoxyphenyl)-...

    6-(4-Methoxyphenyl)-3-pyridazinamine is a GABAA receptor antagonist.

  • Yunaconitine

    Yunaconitine inhibited the increased vascular permeability caused byacetic acid and histamine, the leucocyte migratory response induced by injection of 1 % carrageenin .1 ml in rat's thoracic cavity.

  • 20-(tert-Butoxy)-20-...

    20-(tert-Butoxy)-20-oxoicosanoic acid is a alkyl-chain-based PROTAC linker. 20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).